Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US)
Basel, Switzerland, 7 May 2021 – Lonza today announced significant investments to expand its mammalian drug substance manufacturing facilities in Visp (CH) and Portsmouth (US).